1. Allen, MJ, Vaughan M, Webb A et al. (2000) Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha interferon in patients with metastatic renal cell cancer: a phase II study. Br J Cancer 83(8): 980–985
2. Amato R, Wood LS, Savary C, Wood C, Howkins EA, Reitsma DG, Srivastava P (2999) Patients with renal cell carcinoma (RCC) using autologous tumor-derived heat shock protein-peptide complex (HSPPC-96) with or without interleukin-2 (IL-2). Proc ASCO 2000: abstr. 1782
3. Antonia SJ, Seigne JD (2000) B7–1 gene-modified autologous tumor-cell vaccines for renalcell carcinoma. World J Urol 18: 157–163
4. Atzpodien J, Kirchner HF, Franzke A et al. (1997) Results of a randomized clinical trial comparing sc interleukin-2, sc alpha-2a-interferon, and iv bolus 5-fluorouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients. Proc ASCO, abstr. 1164
5. Atzpodien J, Kirchner H, Bergmann L, Oberneder R, Jonas U, Ganser A (1999) 13cis-retinoic acid, IFN-alpha, IL-2 and chemotherapy in advanced renal cell carcinoma: results of a prospectively randomized trial of the German cooperative renal carcinoma immunotherapy group (DGCIN). Proc ASCO 1999: abstr. 1727